SC
BIIB icon

SRB Corp’s Biogen BIIB Stock Holding History

SRB Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,418
Closed -$404K – 98
2023
Q2 		$404K Buy
+1,418
New +$422K 0.02% 94
2023
Q1 		– Sell
-1,457
Closed -$404K – 116
2022
Q4 		$404K Buy
+1,457
New +$412K 0.03% 92
2022
Q3 		– Sell
-7,641
Closed -$1.56M – 102
2022
Q2 		$1.56M Buy
7,641
+2,329
+44% +$476K 0.1% 22
2022
Q1 		$1.12M Hold
5,312
– – 0.06% 100
2021
Q4 		$1.27M Buy
5,312
+453
+9% +$116K 0.07% 114
2021
Q3 		$1.38M Buy
+4,859
New +$1.59M 0.08% 96
2020
Q4 		– Sell
-2,020
Closed -$573K – 166
2020
Q3 		$573K Buy
2,020
+433
+27% +$121K 0.05% 73
2020
Q2 		$424K Hold
1,587
– – 0.03% 142
2020
Q1 		$502K Buy
+1,587
New +$482K 0.05% 18
2019
Q4 		– Sell
-1,959
Closed -$457K – 149
2019
Q3 		$457K Sell
1,959
-148
-7% -$34.5K 0.04% 131
2019
Q2 		$492K Sell
2,107
-109
-5% -$25.2K 0.05% 116
2019
Q1 		$524K Buy
2,216
+436
+24% +$137K 0.05% 119
2018
Q4 		$536K Buy
+1,780
New +$568K 0.06% 41
2018
Q3 		– Sell
-1,697
Closed -$492K – 168
2018
Q2 		$492K Buy
1,697
+984
+138% +$277K 0.05% 104
2018
Q1 		$195K Buy
713
+91
+15% +$28.2K 0.02% 127
2017
Q4 		$198K Hold
622
– – 0.03% 114
2017
Q3 		$195K Sell
622
-105
-14% -$31.1K 0.03% 39
2017
Q2 		$197K Buy
727
+101
+16% +$26.7K 0.03% 31
2017
Q1 		$171K Buy
626
+88
+16% +$24.9K 0.02% 137
2016
Q4 		$153K Buy
538
+36
+7% +$10.7K 0.02% 162
2016
Q3 		$157K Hold
502
– – 0.02% 90
2016
Q2 		$121K Buy
+502
New +$132K 0.02% 177

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SRB Corp's BIIB Position: Q3 2023 in Review

SRB Corp sold out of Biogen (BIIB) in Q3 2023, closing a stake of 1,418 shares — an estimated $404K sold.

SRB Corp first reported a position in BIIB in Q2 2016 and held it in 22 quarters. The position peaked at $1.56M in Q2 2022. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • SRB Corp reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • SRB Corp sold 1,418 Biogen shares in Q3 2023, an estimated $404K.
  • SRB Corp first reported a position in Biogen in Q2 2016 and held it in 22 quarters.
  • SRB Corp's Biogen position peaked at $1.56M in Q2 2022.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on SRB Corp's 13F filing for Q3 2023, filed 14 Nov 2023.